Exact Mass: 433.1597

Exact Mass Matches: 433.1597

Found 166 metabolites which its exact mass value is equals to given mass value 433.1597, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(2R)-1-[4-[1,3-Benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol

(2R)-1-[4-[1,3-Benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(3,4-difluorophenoxy)propan-2-ol

C22H25F2N3O2S (433.1635)


   

2-Methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid

2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(morpholin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid

C22H22F3N3O3 (433.1613)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents

   

4-Nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate

4-Nitrophenyl 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylic acid

C24H23N3O5 (433.1638)


   

1-(2-Methyl-4-methoxyphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline

1-(4-Methoxy-2-methylphenyl)-4-((2-hydroxyethyl)amino)-6-trifluoromethoxy-2,3-dihydropyrrolo(3,2-c)quinoline

C22H22F3N3O3 (433.1613)


D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors

   

Sarpicillin

Methoxymethyl 6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C21H27N3O5S (433.1671)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(+)-isochromophilone VI

(+)-isochromophilone VI

C23H28ClNO5 (433.1656)


   

2-Hydroxypropyl nortadalafil

2-Hydroxypropyl nortadalafil

C24H23N3O5 (433.1638)


   

JZL195

JZL195

C24H23N3O5 (433.1638)


   

Nitrile,1-O-beta-rutinoside-glucopyranoside,penta-Ac-1,4-Dihydroxy-2-cyclopentene-1-carboxylic acid

Nitrile,1-O-beta-rutinoside-glucopyranoside,penta-Ac-1,4-Dihydroxy-2-cyclopentene-1-carboxylic acid

C18H27NO11 (433.1584)


   

Passibiflorin|Passitrifasciatin

Passibiflorin|Passitrifasciatin

C18H27NO11 (433.1584)


   

C22H27NO6S

C22H27NO6S (433.1559)


   

passitrifasciatin

passitrifasciatin

C18H27NO11 (433.1584)


   

Trp Asp Asn

Trp Asp Asn

C19H23N5O7 (433.1597)


   

Asp Tyr His

Asp Tyr His

C19H23N5O7 (433.1597)


   

Tyr His Asp

Tyr His Asp

C19H23N5O7 (433.1597)


   

His Tyr Asp

His Tyr Asp

C19H23N5O7 (433.1597)


   

Asp His Tyr

Asp His Tyr

C19H23N5O7 (433.1597)


   

Tyr Asp His

Tyr Asp His

C19H23N5O7 (433.1597)


   

His Asp Tyr

His Asp Tyr

C19H23N5O7 (433.1597)


   

12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one

12-[(2,4-dimethoxyphenyl)carbonyl]-6a,6b,10,11,11a,12-hexahydro-8,11-epoxyoxepino[4,5:3,4]pyrrolo[1,2-a]quinolin-7(8H)-one

C25H23NO6 (433.1525)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.276 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.275 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.279

   

Fluvastatin sodium (Lescol)

Fluvastatin sodium (Lescol)

C24H25FNNaO4 (433.1665)


   

[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate

NCGC00347765-02![(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate

C23H28ClNO5 (433.1656)


   

isochromophilone VI

isochromophilone VI

C23H28ClNO5 (433.1656)


   

[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based on: CCMSLIB00000846974]

NCGC00347765-02![(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based on: CCMSLIB00000846974]

C23H28ClNO5 (433.1656)


   

[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based: Match]

NCGC00347765-02![(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl] acetate [IIN-based: Match]

C23H28ClNO5 (433.1656)


   

Cys Asn Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Cys Asn Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Pro Asn Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Gln Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Ser Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Cys Pro Thr Asn

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Cys Gln Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Cys Gln Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Ser Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Cys Ser Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Thr Asn Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Cys Thr Pro Asn

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Asp Gly Gly Trp

(3S)-3-amino-3-({[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]methyl}carbamoyl)propanoic acid

C19H23N5O7 (433.1597)


   

Asp Gly Trp Gly

(3S)-3-amino-3-[({[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)


   

Asp Trp Gly Gly

(3S)-3-amino-3-{[(1S)-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)


   

Gly Asp Gly Trp

(3S)-3-(2-aminoacetamido)-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)


   

Gly Asp Trp Gly

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)


   

Gly Gly Asp Trp

(3S)-3-[2-(2-aminoacetamido)acetamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C19H23N5O7 (433.1597)


   

Gly Gly Trp Asp

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C19H23N5O7 (433.1597)


   

Gly Trp Asp Gly

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)


   

Gly Trp Gly Asp

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C19H23N5O7 (433.1597)


   

Trp Asn Asp

Trp Asn Asp

C19H23N5O7 (433.1597)


   

Asp Trp Asn

Asp Trp Asn

C19H23N5O7 (433.1597)


   

Asp Asn Trp

Asp Asn Trp

C19H23N5O7 (433.1597)


   

Asn Cys Pro Thr

(2S,3R)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Asn Cys Thr Pro

(2S)-1-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Asn Asp Trp

Asn Asp Trp

C19H23N5O7 (433.1597)


   

Asn Pro Cys Thr

(2S,3R)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Asn Pro Thr Cys

(2R)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Asn Thr Cys Pro

(2S)-1-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Asn Thr Pro Cys

(2R)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Asn Thr

(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Gln Ser

(2S)-2-[(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Ser Gln

(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]butanoic acid

C16H27N5O7S (433.1631)


   

Pro Cys Thr Asn

(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanamido]propanoic acid

C16H27N5O7S (433.1631)


   

Pro Asn Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C16H27N5O7S (433.1631)


   

Pro Asn Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Gln Cys Ser

(2S)-2-[(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Pro Gln Ser Cys

(2R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Ser Cys Gln

(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]butanoic acid

C16H27N5O7S (433.1631)


   

Pro Ser Gln Cys

(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Pro Thr Cys Asn

(2S)-3-carbamoyl-2-[(2R)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-sulfanylpropanamido]propanoic acid

C16H27N5O7S (433.1631)


   

Pro Thr Asn Cys

(2R)-2-[(2S)-3-carbamoyl-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Gln Cys Pro Ser

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Gln Cys Ser Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Gln Pro Cys Ser

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C16H27N5O7S (433.1631)


   

Gln Pro Ser Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Gln Ser Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Gln Ser Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Asn Trp Asp

Asn Trp Asp

C19H23N5O7 (433.1597)


   

Ser Cys Pro Gln

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Ser Cys Gln Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Ser Pro Cys Gln

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H27N5O7S (433.1631)


   

Ser Pro Gln Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Ser Gln Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Ser Gln Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Cys Asn Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Thr Cys Pro Asn

(2S)-2-{[(2S)-1-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Asn Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C16H27N5O7S (433.1631)


   

Thr Asn Pro Cys

(2R)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Pro Cys Asn

(2S)-2-[(2R)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C16H27N5O7S (433.1631)


   

Thr Pro Asn Cys

(2R)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C16H27N5O7S (433.1631)


   

Trp Asp Gly Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)propanoic acid

C19H23N5O7 (433.1597)


   

Trp Gly Asp Gly

(3S)-3-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C19H23N5O7 (433.1597)


   

Trp Gly Gly Asp

(2S)-2-(2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}acetamido)butanedioic acid

C19H23N5O7 (433.1597)


   

JZL 195

4-Nitrophenyl 4-(3-phenoxybenzyl)piperazine-1-carboxylate

C24H23N3O5 (433.1638)


   

1H-Pyrazole-4-carboxamide,5-chloro-N-[2-[(3,7-dimethyl-2-quinolinyl)amino]ethyl]-3-methyl-1-phenyl-(9CI)

1H-Pyrazole-4-carboxamide,5-chloro-N-[2-[(3,7-dimethyl-2-quinolinyl)amino]ethyl]-3-methyl-1-phenyl-(9CI)

C24H24ClN5O (433.1669)


   

4-BROMO-N-DODECYL-1-HYDROXY-2-NAPHTHALENECARBOXAMIDE

4-BROMO-N-DODECYL-1-HYDROXY-2-NAPHTHALENECARBOXAMIDE

C23H32BrNO2 (433.1616)


   

Sarpicillin

methoxymethyl (2S,5R,6R)-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C21H27N3O5S (433.1671)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

basic yellow 28

basic yellow 28

C21H27N3O5S (433.1671)


   

Fmoc-N(Hmb)-Gly-OH

Fmoc-N(Hmb)-Gly-OH

C25H23NO6 (433.1525)


   

Tetrabutylammonium periodate

Tetrabutylammonium periodate

C16H36INO4 (433.1689)


   

4-Aminophenyl-beta-D-lactopyranoside

4-Aminophenyl-beta-D-lactopyranoside

C18H27NO11 (433.1584)


   

p-Aminophenyl-beta-D-cellobioside

p-Aminophenyl-beta-D-cellobioside

C18H27NO11 (433.1584)


   

(3S,5S)-Fluvastatin Sodium Salt

(3S,5S)-Fluvastatin Sodium Salt

C24H25FNNaO4 (433.1665)


   

(S)-(4-(3-(BENZYLOXY)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-OXOPROPYL)PHENYL)BORONIC ACID

(S)-(4-(3-(BENZYLOXY)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-OXOPROPYL)PHENYL)BORONIC ACID

C24H24BNO6 (433.1697)


   

Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate

Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate

C26H24FNO4 (433.1689)


   

Fluvastatin sodium

Fluvastatin sodium

C24H25FNNaO4 (433.1665)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor (3S,5R)-Fluvastatin sodium ((3S,5R)-XU 62-320) is the (3S,5R)-enantiomer?of Fluvastatin. Fluvastatin is a first fully synthetic, competitive?HMG-CoA reductase?inhibitor with an IC50?of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1].

   

Lubeluzole

Lubeluzole

C22H25F2N3O2S (433.1635)


D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D002317 - Cardiovascular Agents D020011 - Protective Agents

   

(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate

(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate

C24H23N3O5 (433.1638)


JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively[1].

   

1-(4-(Benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol

1-(4-(Benzo[d]thiazol-2-yl(methyl)amino)piperidin-1-yl)-3-(3,4-difluorophenoxy)propan-2-ol

C22H25F2N3O2S (433.1635)


   

(3r,5s)-Fluvastatin sodium

(3r,5s)-Fluvastatin sodium

C24H25FNNaO4 (433.1665)


C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors (3R,5S)-Fluvastatin ((3R,5S)-XU 62-320) sodium is the 3R,5S-isomer Fluvastatin. Fluvastatin (XU 62-320 free acid) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].

   

NAcM-OPT

NAcM-OPT

C23H29Cl2N3O (433.1688)


   

N-{4-[(1H-benzotriazol-1-ylacetyl)(thiophen-3-ylmethyl)amino]phenyl}-2-methylpropanamide

N-{4-[(1H-benzotriazol-1-ylacetyl)(thiophen-3-ylmethyl)amino]phenyl}-2-methylpropanamide

C23H23N5O2S (433.1572)


   

4-chloro-N-[2-(1H-indol-3-yl)-1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)ethyl]benzamide

4-chloro-N-[2-(1H-indol-3-yl)-1-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)ethyl]benzamide

C24H24ClN5O (433.1669)


   

7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-[(3-methyl-1-piperidinyl)methyl]purine-2,6-dione

7-[(2-Chloro-6-fluorophenyl)methyl]-1,3-dimethyl-8-[(3-methyl-1-piperidinyl)methyl]purine-2,6-dione

C21H25ClFN5O2 (433.1681)


   

Asp-Trp-Asn

Asp-Trp-Asn

C19H23N5O7 (433.1597)


   

Trp-Asn-Asp

Trp-Asn-Asp

C19H23N5O7 (433.1597)


   

Tyr-His-Asp

Tyr-His-Asp

C19H23N5O7 (433.1597)


   

N-(2,5-dimethoxyphenyl)sulfonyl-N-(4-methoxyphenyl)cyclohexanecarboxamide

N-(2,5-dimethoxyphenyl)sulfonyl-N-(4-methoxyphenyl)cyclohexanecarboxamide

C22H27NO6S (433.1559)


   

4-[2-Benzofuranyl(oxo)methyl]-1-[2-(4-morpholinyl)ethyl]-5-(3-pyridinyl)pyrrolidine-2,3-dione

4-[2-Benzofuranyl(oxo)methyl]-1-[2-(4-morpholinyl)ethyl]-5-(3-pyridinyl)pyrrolidine-2,3-dione

C24H23N3O5 (433.1638)


   

N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)


   

(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1R,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)


   

[(2S,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

[(2S,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)


   

[(2S,3S)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

[(2S,3S)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)


   

N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-pyrimidinylmethyl)acetamide

C20H21F2N5O4 (433.1562)


   

N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-pyrazinecarboxamide

C20H24ClN5O4 (433.1517)


   

(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aR,8bR)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)


   

(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

(1S,2aS,8bS)-2-[(2-chlorophenyl)methyl]-1-(hydroxymethyl)-N-phenyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C25H24ClN3O2 (433.1557)


   

cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C21H27N3O5S (433.1671)


   

[(2R,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

[(2R,3R)-1-[(4-chlorophenyl)methyl]-2-(hydroxymethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-(3-pyridinyl)methanone

C25H24ClN3O2 (433.1557)


   

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-methylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C21H27N3O5S (433.1671)


   

Penotonium bromide

Penotonium bromide

C23H32BrNO2 (433.1616)


   

Asn-Asp-Trp

Asn-Asp-Trp

C19H23N5O7 (433.1597)


   

Trp-Asp-Asn

Trp-Asp-Asn

C19H23N5O7 (433.1597)


   

Asn-Trp-Asp

Asn-Trp-Asp

C19H23N5O7 (433.1597)


   

Asp-Asn-Trp

Asp-Asn-Trp

C19H23N5O7 (433.1597)


   

Asp-His-Tyr

Asp-His-Tyr

C19H23N5O7 (433.1597)


   

Asp-Tyr-His

Asp-Tyr-His

C19H23N5O7 (433.1597)


   

His-Asp-Tyr

His-Asp-Tyr

C19H23N5O7 (433.1597)


   

His-Tyr-Asp

His-Tyr-Asp

C19H23N5O7 (433.1597)


   

Tyr-Asp-His

Tyr-Asp-His

C19H23N5O7 (433.1597)


   

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione

5-(3,4-Dimethoxyphenyl)-4-(furan-2-carbonyl)-1-(2-phenylethyl)pyrrolidine-2,3-dione

C25H23NO6 (433.1525)


   

Fluvastatin (sodium)

Fluvastatin (sodium)

C24H25FNNaO4 (433.1665)


Fluvastatin sodium (XU 62320) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin sodium protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].

   

(7s)-5-chloro-3-[(1e,3e,5r)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

(7s)-5-chloro-3-[(1e,3e,5r)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

C23H28ClNO5 (433.1656)


   

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1r,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

(2e)-n-[2-(4-{[(2e)-3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

(2e)-n-[2-(4-{[(2e)-3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

C22H27NO6S (433.1559)


   

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

(7r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

C23H28ClNO5 (433.1656)


   

(7r)-5-chloro-3-[(1e,3z,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

(7r)-5-chloro-3-[(1e,3z,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

C23H28ClNO5 (433.1656)


   

1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxycyclopent-2-ene-1-carbonitrile

1-{[3,4-dihydroxy-6-(hydroxymethyl)-5-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxycyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

n-[2-(4-{[3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

n-[2-(4-{[3-(5,5-dimethyl-4-oxofuran-2-yl)but-2-en-1-yl]oxy}phenyl)ethyl]-3-methanesulfonylprop-2-enimidic acid

C22H27NO6S (433.1559)


   

4-hydroxy-1-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]cyclopent-2-ene-1-carbonitrile

4-hydroxy-1-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

4-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

4-[(4,5,6-trihydroxy-3-methyloxan-2-yl)oxy]-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1s,4s)-4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

(1s,4r)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

(1s,4r)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

4-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO11 (433.1584)


   

(7s)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

(7s)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

C23H28ClNO5 (433.1656)


   

5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

5-chloro-3-(3,5-dimethylhepta-1,3-dien-1-yl)-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl acetate

C23H28ClNO5 (433.1656)